Analyst Ratings for 9 Meter Biopharma (NMTR)
NMTR Rating Summary
NMTR Price Target Summary
- Highest: $0.75 (Citi)
- Lowest: $0.75 (Citi)
- Average: $0.75
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$0.75 (+971.4%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
Avg. $ Target:
$0.75 (+971.4%)
* Over Last 12-Mos
Rating Score: 4.3 / 10
Percentile Rank: 43%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/26/2023 | Brookline Capital Markets | Kemp Dolliver | Downgrade | Hold (Buy) |
N/A (N/A) |
0.78 (0.07) |
-91.03% | Details |
| 3/20/2023 | Truist Securities | Srikripa Devarakonda | Downgrade | Hold (Buy) |
N/A (N/A) |
1.41 (0.07) |
-95.04% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
